PolyPid Ltd.
Symbool: PYPD
NASDAQ
4.94
USDMarktprijs vandaag
-0.3367
Koers/Winst Verhouding
0.0009
Koers/Winst Groei Verhouding
8.17M
MRK Kapitalisatie
- 0.00%
DIV Rendement
PolyPid Ltd. Structuur van het management
Informatie over het management
Naam | Titel |
---|---|
Ms. Dalit Hazan | Executive Vice President of R&D and Clinical & Regulatory Affairs |
Mr. Jonny Missulawin | Chief Financial Officer |
Mr. Ori Warshavsky | Chief Operating Officer - US |
Mr. Tal Vilnai | General Counsel & Corporate Secretary |
Ms. Dikla Czaczkes Akselbrad | Chief Executive Officer & Director |
Ms. Maria Rubin | Vice President of Operations |
Ms. Rivi Lev-ari | Vice President of Human Resource |
Dr. Jean-Marc Hagai Pharm.D. | Chief Commercial Officer |
Vergelijkbare aandelen
Misschien ben je ook geïnteresseerd in:SRNE
Topmanagement:
- Dr. Scott Schaus
- Dr. Henry H. Ji P...
MRVI
Topmanagement:
- Ms. Debra Hart
- Ms. Rebecca Buzzeo
- Dr. Kate E. Brode...
CMRA
Topmanagement:
- Ms. Janice Marie ...
- Dr. David Soane ...
- Mr. Michael G. Ca...
GUBRA.CO
Topmanagement:
- Ms. Trine Nygaard...
- Mr. Kristoffer R...
- Ms. Margit Bloch ...
T5O.DE
Topmanagement:
- Dr. Mark-André F...
- Dr. Dirk Kaiser
- Dr. Bruno Rosen
6826.HK
Topmanagement:
- Ms. Caixia Ren
- Mr. Ming King Ch...
- Ms. Min Tian
PPBT
Topmanagement:
- Mr. Ido Morpurgo...
- Mr. Lior Fhima C...
- Dr. Michael Schi...